Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.42 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | KIF18A | Q8NI77 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57363 | 0.88 | CA1 (0.43) | KMT2ARAB9AMEN1AGTR1MAPT | |
| SCHEMBL16429380 | 0.86 | KMT2A (0.44) | KMT2ARAB9AMEN1MAPTNPSR1 | |
| SCHEMBL28974082 | 0.75 | HTR6 (0.46) | AGTR1MAPTHTR6ALDH1A1LMNA | |
| SCHEMBL15569858 | 0.75 | CA2 (0.39) | KMT2AMEN1ALDH1A1 | |
| SCHEMBL27825213 | 0.73 | L3MBTL1 (0.47) | KMT2AMEN1MAPTHTR6ALDH1A1 | |
| SCHEMBL990710 | 0.70 | MAPT (0.48) | KMT2ARAB9AMEN1MAPTALDH1A1 | |
| SCHEMBL28746965 | 0.70 | HTR6 (0.41) | KMT2AMAPTHTR6ALDH1A1AKR1B1 | |
| SCHEMBL15689562 | 0.69 | AGTR1 (0.54) | KMT2ARAB9AMEN1AGTR1MAPT | |
| SCHEMBL11062765 | 0.69 | AGTR1 (0.50) | KMT2ARAB9AMEN1AGTR1MAPT | |
| SCHEMBL9370007 | 0.68 | ALDH1A1 (0.33) | KMT2AMEN1MAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403862-B2 | Reagent controlled stereoselective glycosylation | TRUSTEES OF TUFTS COLLEGE (US) | 2016-08-02 | — | — | US | claimed |
| US-6486191-B2 | FUNGICIDAL ACTIVITY | BAYER AG (DE) | 2002-11-26 | — | — | US | claimed |
| US-20020094936-A1 | Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests | ASSMANN LUTZ (DE) | 2002-07-18 | — | — | US | claimed |
| US-6350770-B1 | MICROBIOCIDES, INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-02-26 | — | — | US | claimed |
| US-20020022728-A1 | Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests | ASSMANN LUTZ (DE) | 2002-02-21 | — | — | US | claimed |
| US-6262100-B1 | Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests | BAYER AKTIENGESELLSCHAFT (DE) | 2001-07-17 | — | — | US | claimed |
| CN-1264367-A | Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests | BAYER AG (DE) | 2000-08-23 | — | — | CN | claimed |
| EP-1003726-A1 | NITROPHENYL-SULFONYL-IMIDAZOLES AND USE THEREOF FOR CONTROLLING VEGETABLE AND ANIMAL PESTS | Bayer Aktiengesellschaft (DE) | 2000-05-31 | — | — | EP | claimed |
| WO-1999005116-A1 | NITROPHENYL-SULFONYL-IMIDAZOLES AND USE THEREOF FOR CONTROLLING VEGETABLE AND ANIMAL PESTS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-02-04 | — | — | WO | claimed |
| EP-2201001-B1 | NOVEL IMIDAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2011-09-14 | — | — | EP | disclosed |
| EP-2201000-B1 | NOVEL IMIDAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2011-08-31 | — | — | EP | disclosed |
| US-6486191-B2 | FUNGICIDAL ACTIVITY | BAYER AG (DE) | 2002-11-26 | — | — | US | disclosed |
| US-6486191-B2 | FUNGICIDAL ACTIVITY | BAYER AG (DE) | 2002-11-26 | — | — | US | disclosed |
| US-6486191-B2 | FUNGICIDAL ACTIVITY | BAYER AG (DE) | 2002-11-26 | — | — | US | disclosed |
| US-4474947-A | Benzazolides and their employment in phosphate ester oligonucleotide synthesis processes | BIOSEARCH (US) | 1984-10-02 | — | — | US | disclosed |
| US-4426517-A | Process for de-cyanoethylating blocked nucleotides | ELI LILLY AND COMPANY (US) | 1984-01-17 | — | — | US | disclosed |
| US-4419509-A | Process for de-cyanoethylating blocked nucleotides | ELI LILLY AND COMPANY (US) | 1983-12-06 | — | — | US | disclosed |
| US-4417046-A | Process for isolating oligonucleotide product from a coupling reaction mixture | ELI LILLY AND COMPANY (US) | 1983-11-22 | — | — | US | disclosed |
| EP-0075392-A1 | Process for de-cyanoethylating blocked nucleotides | ELI LILLY AND COMPANY (US) | 1983-03-30 | — | — | EP | disclosed |
| EP-0002322-A2 | Improved Triester process for the synthesis of oligonucleotides | GENENTECH, INC. (US) | 1979-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020022728-A1 | Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests | NOD1, NMRAL1, NAT1 | KMT2A 1335/4885RAB9A 652/4885MEN1 2749/4885 |
| US-20020094936-A1 | Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests | NOD1, NMRAL1, NAT1 | KMT2A 1335/4885RAB9A 652/4885MEN1 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.